9 research outputs found
Intraocular lenses in age-related macular degeneration
Purpose:
The aim of this work is to review the lenses, assessing their advantages and disadvantages. We describe a total of seven types of intraocular lenses (IOLs) recommended for age-related macular degeneration (AMD).
Methods:
We used the PubMed web platform to search for implantable devices in various stages of AMD. We searched for both prospective and retrospective studies and also case reports.
Results:
Clinical results in AMD patients have been described for a total of seven types of IOLs recommended for AMD: an implantable miniature telescope (IMT), IOL-VIP System, Lipshitz macular implant (LMI), sulcus-implanted Lipshitz macular implant, LMI-SI, Fresnel Prism Intraocular Lens, iolAMD and Scharioth Macula Lens.
Conclusions:
We conclude that to objectively ascertain the effectiveness and safety of these lenses, further independent clinical studies with longer follow-up data are necessary prior to the general use of these optical devices
Considerações para elaboração de protocolo de assistência ortodôntica em saúde coletiva
Assessment of the Effect of Orthodontic Treatment on the Periodontal Health of Endodontically Restored Tooth
A Discussion of Commercially Available Intra-ocular Telescopic Implants for Patients with Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is the
leading cause of visual impairment in the
western world, causing significant reduction in
quality of life. Despite treatment advances, the
burden of visual impairment caused by AMD
continues to rise. In addition to traditional low
vision rehabilitation and support, optical and
electronic aids, and strategies to enhance the
use of peripheral vision, implantable telescopic
devices have been indicated as a surgical means
of enhancing vision. Here we examine the literature on commercially available telescopic
devices discussing their design, mode of action,
surgical procedure and published outcomes on
visual acuity, quality of life, surgical complication rates and cost effectiveness data where
available
